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Abstract
Biofilm formation and adherence of bacteria to host tissue are one of the most important virulence
factors of methicillin-resistant strains of Staphylococcus aureus (MRSA). The number of resistant
strains is seriously increasing during the past years and bacteria have become resistant, not only to
methicillin, but also to other commonly used antistaphylococcal antibiotics. There is a great need for
discovering a novel antimicrobial agent for the treatment of staphylococcal infections. One of the
most promising groups of compounds appears to be chalcones. In present study we evaluated the in
vitro effect of three newly synthesized chalcones: 1,3- Bis-(2-hydroxy-phenyl)-propenone, 3-(3-
Hydroxy-phenyl)-1-(2-hydroxy-phenyl)-propenone and 3-(4-Hydroxy-phenyl)-1-(2-hydroxy-
phenyl)-propenone on glycocalyx production, biofilm formation and adherence to human fibronectin
of clinical isolates and laboratory control strain of MRSA (ATCC 43300). Subinhibitory concentra-
tions of the tested compounds reduced the production of glycocalyx, biofilm formation and adher-
ence to human fibronectin of all MRSA strains. Inhibition of biofilm formation was dose dependent
and the most effective was 1,3- Bis-(2-hydroxy-phenyl)-propenone. In our study we demonstrated
that three newly-synthesized chalcones exhibited significant effect on adherence and biofilm forma-
tion of MRSA strains. Chalcones may be considered as promising new antimicrobial agents that can
be used for prevention of staphylococcal infections or as adjunct to antibiotics in conventional ther-
apy.
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Introduction
Staphylococcus aureus is one of the most frequent
pathogen that cause broad spectrum of nosocomial and
community-acquired infections. At the beginning, with the
development of beta-lactamase resistant penicillins, such
as methicillin in the early 1960s, there has been a great im-
provement in the treatment of staphylococcal infections.
Nevertheless, the first methicillin-resistant strains of Staph-
ylococcus aureus (i.e. MRSA) emerged during the first
year of methicillin usage, and their number is continuously
increasing in passed several decades making MRSA infec-
tions a serious clinical and therapeutical problem (Garau et
al., 2009).
Among various virulence factors of S. aureus respon-
sible for different purulent or toxic infections, biofilm for-
mation has been recognized as the most important for
prolonged and recurrent infections with these bacteria.
Biofilm is a complex multilayer structure that forms on the
polymer surfaces of implanted medical devices. The two
step process of biofilm formation consists of the adherence
of bacteria to the surface followed by the aggregation of
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bacteria and formation of multilayer structure. Bacteria in
biofilm are connected with amorphous slimy material na-
med polysaccharide intercellular adhesin (Gotz, 2004) that
acts as specific cell glue making this layer very adherent
and more tolerant to both environmental factors (Rode et
al., 2007) and antimicrobial agents (Heiby et al., 2010).
The slimy material is not a true capsule since it is loosely
bound to the staphylococcal surface and it is believed that it
plays essential role in bacterial contamination of medical
devices. Staphylococci do not form biofilms only on artifi-
cial implants. It has been recognized that they also possess
the ability to bind to the different components of extra-
cellular matrix and colonize the surface of mammalian host
cells (Gotz, 2002). This specific adherence is not mediated
by the production of glycocalyx, but rather by adhesins like
fibronectin-binding proteins A and B, collagen-binding
protein Cna, fibrinogen-binding proteins, clumping factor
A and B and others (Foster and Höök, 1998; Van Belkum et
al., 2002). Beside the advanced epidemiological measures
developed for minimizing the spread of the resistant strains
in environment and between humans, there is a great need
for a discovery of a novel antimicrobial compounds that
will improve the treatment of MRSA infections.
Chalcones belong to a group of flavonoides, naturally
occurring compounds biosynthesized in various plant spe-
cies, fruits and vegetables. Chemical structure of these
compounds is made of two aryl rings linked by a ,-unsat-
urated ketone. So far it has been proved that different
chalcones possess a broad spectrum of potent biological ac-
tivities: antibacterial, antiviral, antifungal, antiangiogenic,
anticancer, antiproliferative and anti-inflammatory (Nowa-
kowska, 2007; Mojzis et al., 2008; Kontogiorgios et al.,
2008; Boumendjel et al., 2009; Batovska and Todorova,
2010). Beside chalcones isolated from natural sources,
many chalcones and their analogues can be obtained by the
methods of classical and combinatorial synthesis.
Since the first step of the colonization and host-cell
invasion is staphylococcal adhesion to the components of
the extracellular matrix and cell surface (Foster and Höök,
1998; Sinha and Fraunholz, 2010) our interest was to inves-
tigate the influence of the three newly-synthesized
chalcones on biofilm formation, slime production and bind-
ing to fibronectin of 30 different MRSA strains. The anti-
adhesive activity of 1,3- Bis-(2-hydroxy-phenyl)-prope-
none, 3-(3-Hydroxy-phenyl)-1-(2-hydroxy-phenyl)-prope-
none and 3-(4-Hydroxy-phenyl)-1-(2-hydroxy-phenyl)-
propenone against MRSA strains was investigated for the
first time.
Methods
Bacterial strains and culture media
The influence of chalcones on adhesive properties of
staphylococci was tested using 30 clinical isolates of
MRSA obtained from blood (3), wound (11), sputum (3),
endotracheal tube (3), tracheostoma (2), abdominal drain
(2), nose (2), skin (1), urine (1), urethra (1) and external au-
ditory canal (1). Identification of the isolates and methi-
cillin resistance were determined by VITEK 2 test cards GP
and AST-P580 (bioMérieux, France) and confirmed by
PCR for nuc (Brakstad et al., 1992) and mecA (Bignardi et
al., 1996) genes. One laboratory control strain of methi-
cillin-resistant S. aureus ATCC 43300 (KWIK-STIKTM,
Microbiologics, USA) was used as positive control. Clini-
cal isolates of MRSA were stored at -70 °C in brain heart in-
fusion broth (BHI; Lab M Limited, UK) with the addition
of 10% sterile glycerol. Prior to experiment, bacteria were
defrosted, inoculated on tryptic soy agar (TSA; Lab M
Limited) and cultivated in aerobic conditions for 18-24 h at
35 °C.
Chalcones
The effect of the newly synthesized chalcones 1,3-
Bis-(2-hydroxy-phenyl)-propenone (further referred as O-
OH), 3-(3-Hydroxy-phenyl)-1-(2-hydroxy-phenyl)-prope-
none (further referred as M-OH) and 3-(4-Hydroxy-
phenyl)-1-(2-hydroxy-phenyl)-propenone (further referred
as P-OH) on adhesive properties of MRSA was investi-
gated for the first time. All three tested compounds were
obtained from the Department of Pharmaceutical Chemis-
try, University of Belgrade-Faculty of Pharmacy, Serbia.
Chalcones were prepared through base catalyzed Claisen-
Schmidt condensation of ortho, metha or para hydroxy
substituted benzaldehydes with 2-hydroxy acetophenones.
Synthesized compounds were characterized by IR, NMR
and mass spectrometry. The purity of the compounds was
checked using HPLC and TLC methods. The structures of
investigated chalcones are presented in Table 1.
Subinhibitory concentrations of the tested com-
pounds previously determined by broth microdilution test
(0.5 x minimal inhibitory concentration, MIC) were used
for the detection of the effect of chalcones on glycocalyx
production, biofilm formation and adherence to human
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Table 1 - The chemical structures of the tested chalcones: 1,3- Bis-(2-hy-
droxy-phenyl)-propenone (further referred as O-OH), 3-(3-Hydroxy-
phenyl)-1-(2-hydroxy-phenyl)-propenone (further referred as M-OH) and
3-(4-Hydroxy-phenyl)-1-(2-hydroxy-phenyl)-propenone (further referred
as P-OH).
Compound R1 R2 R3
O-OH - OH - H - H
M-OH - H - OH - H
P-OH - H - H - OH
fibronectin. Prior to experiments, chalcones were dissolved
in sterile dimethyl sulphoxide (DMSO; Sigma-Aldrich,
USA) to a stock solution of 1000 g/mL and subsequently
diluted to the desired concentrations with medium.
Production of glycocalyx
Glycocalyx production was detected by Congo-red
agar method (Freeman et al., 1989) and Christensen
method (Christensen et al., 1982). For detection of glyco-
calyx production in the presence of chalcones, we used
subinhibitory concentrations of chalcones (50 g/mL for
M-OH and P-OH and 25 g/mL for O-OH) prepared in
tryptone soy broth (TSB; Lab M Limited). Inoculum of
bacteria (0.5 McFarland) was incubated at 35 °C in aerobic
conditions in 2 mL of TSB-chalcone dilution in 24-well
plates (Sarstedt, USA) for Congo red agar method (CRA)
or in test tubes for Christensen method. Positive controls of
each strain were incubated under the same conditions with-
out presence of chalcones. Each test was repeated three
times.
Congo red agar method
Bacterial strains were incubated with chalcones (for
24 h or 48 h) and then bacteria were inoculated on plates
containing 20 mL of brain heart infusion agar (Himedia, In-
dia) supplemented with 5% saccharose and 0.08% Congo
red (Fisher scientific, UK). Plates were incubated on 35 °C
in aerobic conditions for 24 h after which results were inter-
preted according to following criteria: black colonies with
dry crystalline consistency indicated for the positive result
(slime production), pink colonies were usually present at
non-slime producers and darkening of the colonies with the
absence of the dry-crystalline morphology was categorized
as indeterminate result (Freeman et al., 1989: Cree et al.,
1995).
Christensen method
After 48 h of cultivation of the bacteria in the static
conditions, test tubes were gently decanted and 1 mL of
0.4% aqueous solution of trypan blue (BDH chemicals Ltd,
UK) was added to each tube. Tubes were slowly rotated in
order to achieve uniform staining of the remnant slime and
tubes were dried upside down. Bacterial strain was catego-
rized as a slime producer if colored precipitate was ob-
served at the bottom of the test tube (Christensen et al.,
1982; Freeman et al., 1989).
Biofilm assay
Biofilm formation was tested in 96-well microtiter
plates according to Stepanovic et al. (2007). One colony of
the overnight cultures of bacterial strains was diluted in sa-
line in order to adjust the turbidity of the bacterial suspen-
sion to 0.5 McFarland standard (approximately
108 cfu/mL).
Serial dilutions of chalcones (12.5, 25 and 50 g/mL
for M-OH and P-OH and 6.25, 12.5 and 25 g/mL for
O-OH) were prepared in fresh TSB (supplemented with ad-
ditional 1% glucose) or BHI (supplemented with additional
2% glucose and 2% saccharose) according to Knobloch et
al. (2002) and 180 L of each dilution was poured in tripli-
cates into microtiter plate. A 20 L of previously prepared
bacterial suspension was added to each well. Positive con-
trols of each strain (bacteria in medium without presence of
chalcones) were incubated under the same conditions. Neg-
ative control for each plate was medium solely. After 24 h
of incubation at 35 °C in aerobic conditions plates were de-
canted and rinsed gently three times with 300 L of sterile
phosphate-buffered saline (PBS; pH 7.2). After air drying
plates were fixed with 150 L methanol per well for
20 min, dried and stained with 150 L (per well) of 2%
crystal violet (Himedia) for 15 min. Unbounded dye was
rinsed with water and dye bounded to the cell wall of adher-
ent bacteria was released with 150 L of 96% ethanol/well
for 20 min. Optical density (OD) was measured at 570 nm
using a microtiter plate reader (ICN Flow Titertek
Multiscan Plus) following the calculation of the results ac-
cording to Stepanovic et al. (2000). Each assay was re-
peated three times on three consecutive days. Since all tests
were performed in triplicate and repeated three times, the
average OD values were calculated for all tested strains and
negative controls. To calculate the category of biofilm pro-
duction, we determined the cut-off optical density (ODc) as
three standard deviations above the mean OD of the nega-
tive control. According to the obtained results all tested
strains were divided into four groups:
OD  ODc - category 0 (non-adherent strain, no
biofilm producer)
ODc < OD  2xODc - category 1 (weak biofilm pro-
ducer)
2xODc < OD  4xODc - category 2 (moderate
biofilm producer)
4xODc < OD - category 3 (strong biofilm producer)
Microtiter plate adhesion assay
Adhesion of tested bacterial strains to human fibro-
nectin was evaluated according to Peacock et al. (2000).
All tested strains of staphylococci were preincubated for
24 h and 48 h in the presence of subinhibitory concentra-
tions of chalcones in 24 well plates as previously described
in the section of production of glycocalyx. Each isolate had
its own positive control (bacteria cultivated solely in me-
dium at the same laboratory conditions).
Polysorp microtiter plates (NUNC, Denmark) were
coated for 1 h at 37 °C with 25 g/mL of human fibronectin
(Serva, Germany). After overnight blockage of the remain-
ing sites at 4 °C with 200 L of 2% bovine serum albumine
(Sigma-Aldrich) in PBS, plates were washed three times
with PBS and inoculum of 1x108 bacteria in PBS/well was
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added in triplicates to each well. Plates were incubated 1 h
at 37 °C, rinsed three times with PBS, fixed with 2%
glutaraldehyde (TCI Europe) in PBS for 1 h and stained
with crystal violet for 5 min. After rinsing with water and
air drying, the absorbance was measured at OD405. Two
triplicates of PBS without bacteria served as a negative
control for each plate. After calculation of the results,
absorbance values were expressed as the percentage of the
absorbance of the positive control. Each assay was repeated
three times.
Statistical analysis
The data obtained in this study were analyzed in
SPSS statistical program (PASW statistics 18.0 version)
using Student’s t-test.
Results
Glycocalyx production of MRSA strains
The results obtained from Congo red agar method
showed that 25/31 (80.6%) of strains (including control
MRSA strain ATCC 43300) formed black colonies indicat-
ing for positive production of glycocalyx, while 6/31
(19.4%) of strains had indeterminate result since they
formed dark pink-red colonies without dry crystalline mor-
phology. Production of glycocalyx observed by Christen-
sen method confirmed slime production for 21/31 (67.7%)
of strains while 4/31 (12.9%) of strains had discrepancy
with CRA method. After precultivation in the presence of
chalcones, all three tested compounds exerted significant
inhibitory effect on the slime production detected by both
methods. O-OH chalcone was the most effective since
25/31 (80.6%) of strains reduced the glycocalyx produc-
tion, following P-OH with 22/31 (71%) and M-OH with
20/31 (64.5%) respectively.
Biofilm production of MRSA strains
Biofilm formation was investigated for 30 clinical
strains and one control strain of MRSA ATCC 43300 in
three independent experiments during three consecutive
days. According to these results, all tested strains showed
ability to form biofilm as following: 1/31 strain (3.2%) was
low biofilm producer, 15/31 strains (48.4%) showed mod-
erate biofilm production and 15/31 strains (48.4%) were
strong biofilm producers. Category of biofilm production
of MRSA strains isolated from different specimens is pre-
sented in Table 2. The ability of biofilm production was ob-
served after 24 h and 48 h with no statistically significant
difference between results (p > 0.05, data not shown). Con-
cerning this, we decided to estimate production of biofilm
after 24 h of incubation in the presence of chalcones.
Inhibition of biofilm production was dose dependent
with most of the strains showing no production or low
biofilm production at highest concentration of chalcones
applied (Table 3). The most significant suppression of the
biofilm production exhibited O-OH chalcone since all of
the strains with moderate/strong biofilm production de-
creased biofilm formation in the presence of the lowest
concentration (6.25 g/mL) of the tested compound. Only
1 strain (belonging to a group of weak biofilm producers)
reached the level of the positive control. P-OH and M-OH
chalcones applied at the lowest concentration (12.5 g/mL)
had a slightly weaker effect compared to O-OH with 13/31
(42%) of strains reaching the level of the positive control
for P-OH and 18/31 of strains (58%) for M-OH respec-
tively (Table 3).
Binding of MRSA strains to human fibronectin
All tested MRSA strains had similar capability of
binding to immobilized fibronectin. After 24 h of incuba-
tion in the presence of chalcones we detected statistically
significant decrease in fibronectin binding compared to un-
treated controls as following: 22/31 (71%) of strains
reduced binding to fibronectin after cultivation in the pres-
ence of O-OH chalcone, 24/31 (77.4%) of strains in the
presence of M-OH and 27/31 (87%) % in the presence of
P-OH respectively (Table 4). Strains that were primary re-
sistant to the effect of chalcones during the 24 h incubation
significantly reduced fibronectin-binding ability after pro-
longed incubation of bacteria for 48 h in the presence of the
tested compounds (p < 0.05, data not shown). There was no
statistically significant difference in binding to human
fibronectin between MRSA strains isolated from respira-
tory tract, wound, blood and other specimens after 24/48 h
of incubation in the presence of the tested chalcones
(p > 0.05, data not shown).
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Table 2 - Category of biofilm production of MRSA strains.
Specimen N° of
strains
Category of biofilm production
1 2 3
blood 3 - 3 -
wound swab 11 - 5 6
endotracheal tube swab 3 - 1 2
sputum 3 1 1 1
tracheostomal swab 2 - 1 1
abdominal drain swab 2 - 1 1
nose swab 2 - - 2
skin swab 1 - - 1
urine 1 - 1 -
urethral swab 1 - 1 -
external auditory canal
swab
1 - - 1
ATCC 43300 1 - 1 -

31 1 15 15
1-weak biofilm producer, 2-moderate biofilm producer, 3-strong biofilm
producer.
Discussion
Antimicrobial activity of chalcones is well docu-
mented and dependent on their chemical structure (Nielsen
et al., 2005; Nowakowska, 2007; Batovska and Todorova,
2010). Our preliminary results showed that all three newly
synthesized compounds have inhibitory activity against
MRSA with MIC values ranging from 50-75 g/mL for
O-OH chalcone and 75-125 g/mL for M-OH and P-OH
chalcone (data not shown). Other authors reported similar
activity of various chalcones against MRSA. Hatano et al.
(2000) and Fukai et al. (2002) found that Licochalcone A
isolated from liquorice (rooth and rhizome of Glycyrrhiza
spp.) exerted antibacterial activity against MRSA with
MIC values ranging from 6.25-16 g/mL depending on the
strain of microorganism. Besides naturally occurring chal-
cones, it has been reported that synthesized chalcones also
possess strong anti-MRSA activity. Bowman et al. (2007)
identified 5 antibacterial compounds out of 198 investi-
gated chalcones among which one chalcone exerted stron-
ger anti-MRSA activity with MIC value 3.0 M compared
to MIC value 8.0 M of linezolid. Trihidroxychalcones, as
newly synthesized 2.4.2’-trihidroxy-5’-methylchalcone in-
vestigated by Sato et al. (1996) exerted antistaphylococcal
activity against 19 MRSA isolates with complete growth
inhibition at 50 g/mL and one strain at 25 g/mL.
In our study we found that incubation of MRSA
strains in the presence of subinhibitory concentrations of
chalcones significantly reduced the production of glyco-
calyx detected by CRA and Christensen method. Discrep-
ancy between these two methods was low and in accor-
dance with the results of other authors (Freeman et al.,
1989; Cree et al., 1995). CRA and Christhensen methods
are qualitative and not 100% reliable since Christhensen
method shows low success for detection of weak slime pro-
duction (Christensen et al., 1982) and results obtained from
CRA method can often be misinterpreted due to variation in
black pigmentation of colonies or decrease of the black
color with the time (Freeman et al., 1989; Mariana et al.,
2009). To evade the subjectivity of the beholder, we per-
formed a quantitative microtiter-plate biofilm assay and
confirmed the biofilm production in all tested strains of
MRSA. Inhibition of biofilm formation in the presence of
chalcones was dose dependent and most of the strains did
not reach the level of the untreated controls at the lowest
concentration of chalcones applied. Fibronectin-binding of
MRSA strains was also diminished after precultivation in
the presence of the tested chalcones indicating that bacteria
reduced their ability to adhere to a host tissue as well as to
plastic polymer surfaces.
Since the survival of bacteria, biofilm production and
adherence to fibronectin-binding proteins are unrelated
events we can presume that some specific chemical feature
of the tested compounds influences some general processes
in bacterial cells. Although antimicrobial activity of chal-
cones cannot be assigned to a presence of merely one func-
tional group, several studies reported the same structural
patterns of different investigated compounds. The most sig-
nificant structural characteristics responsible for antista-
phylococcal activity of the chalcones are presence of the
OH group and lipophilicity of the molecule (Nowakowska,
2007). Alcaraz et al. (2000) confirmed that chalcones with
highest anti-MRSA activity are open chain flavonoids
whose basic structure includes two aromatic rings bound by
an ,-unsaturated carbonyl group. Presence of the OH
group at 2’ or 2’.4’ position of B ring is essential for
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Table 3 - Production of biofilm after 24 h cultivation of MRSA strains in the presence of O-OH, M-OH and P-OH chalcones.
Biofilm production of con-
trol strain (n° of strains)
Biofilm production after precultivation in the presence of chalcones
O-OH (g/mL) M-OH (g/mL) P-OH (g/mL)
Category 6.25 12.5 25 12.5 25 50 12.5 25 50
Weak (1/31) 0 - 1/1 1/1 - 1/1 1/1 - - -
1 1/1 - - 1/1 - - 1/1 1/1 1/1
2 - - - - - - - - -
3 - - - - - - - - -
Moderate (15/31) 0 6/15 11/15 11/15 - - 5/15 - - 2/15
1 9/15 4/15 4/15 5/15 14/15 10/15 10/15 14/15 13/15
2 - - - 10/15 1/15 - 5/15 1/15 -
3 - - - - - - - - -
Strong (15/31) 0 2/15 6/15 9/15 - - - - - -
1 13/15 9/15 6/15 - 3/15 11/15 - 5/15 10/15
2 - - - 8/15 10/15 4/15 8/15 8/15 3/15
3 - - - 7/15 2/15 - 7/15 2/15 2/15
0-no biofilm production, 1-weak biofilm producer, 2-moderate biofilm producer, 3-strong biofilm producer.
anti-MRSA activity of these compounds with MIC values
ranging from 12.7-38.7 g/mL (Alcaraz et al., 2000). Kro-
mann et al. (2004) showed that the free hydroxyl group in
4’ position of ring B is necessary for the antistaphylococcal
activity of licochalcone A analogues.
Results of this research are in agreement with findings
of Alcaraz et al. (2000) and Kromann et al. (2004). We can
propose that anti-MRSA activity of the O-OH, M-OH and
P-OH chalcones is due to presence of the carbonyl group and
functional OH group in the 2’, 3’ or 4’ position of B ring.
Precise mechanism of antimicrobial effect of differ-
ent chalcones is still unknown. Other pharmacological
compounds with carbonyl group exert their action through
direct interaction with some enzymes usually through hy-
drogen bonds. Ohemeng et al. (1993) screened 14 flavo-
noids of varying structure for inhibitory activity against
DNA gyrase and found that enzyme inhibition was limited
to those compounds with B-ring hydroxylation. Not only
do certain flavonoids inhibit DNA synthesis but they can
also affect RNA synthesis in S. aureus (Mori et al., 1987).
Other enzymes involved in metabolism of macromolecules
(DNA, RNA, carbohydrates and proteins) can also be af-
fected in S. aureus. Haraguchi et al. (1998) demonstrated
that licochalcones may be interfering with energy metabo-
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Table 4 - Fibronectin binding of MRSA strains after 24 h cultivation in the presence of chalcones.
No of strain O-OH 24 h 25 g/mL M-OH 24 h 50 g/mL P-OH 24 h 50 g/mL Control 24 h
3 66.7  2.7 * 71.7  12.4 66.0  1.3 * 100.0  8.0
4 73.7  1.1 ** 63.7  5.2 ** 77.9  8.6 100.0  3.8
5 69.4  0.6 ** 60.1  1.3 ** 55.1  2.8 ** 100.0  3.5
6 68.0  4.0 * 80.3  4.6 * 64.1  1.4 ** 100.0  4.1
7 55.1  4.0 * 63.5  15.2 55.6  0.4 * 100.0  10.0
8 63.1  8.0 * 65.5  0.5 * 59.5  0.6 ** 100.0  5.1
10 56.4  1.5 * 75.2  11.4 * 66.7  2.6 * 100.0  7.7
12 54.3  1.5 61.1  3.9 62.7  7.6 100.0  12.3
13 71.3  8.0 * 65.5  6.3 * 58.6  1.4 ** 100.0  3.7
14 68.2  8.6 58.9  0.7 * 52.2  1.4 * 100.0  12.1
15 66.0  5.5 * 66.7  1.4 ** 79.6  5.7 * 100.0  4.1
16 56.8  11.1 * 50.9  1.4 *** 49.4  2.8 *** 100.0  1.0
17 57.4  7.3 ** 68.0  13.5 63.3  14.5 * 100.0  0.8
18 52.2  1.4 * 56.8  12.9 49.6  0.3 * 100.0  9.9
19 31.2  8.3 * 27.5  3.1 * 30.6  14.1 * 100.0  11.7
20 59.3  9.7 * 39.4  4.4 ** 40.7  5.7 ** 100.0  3.4
21 73.7  7.3 * 55.9  6.4 ** 53.3  3.4 ** 100.0  1.3
24 62.8  1.5 ** 59.5  9.2 ** 57.0  3.2 ** 100.0  1.4
25 38.2  4.3 * 43.5  1.3 * 42.4  2.6 * 100.0  13.9
26 35.3  8.0 36.3  1.3 39.7  15.4 100.0  17.7
27 48.5  6.1 55.8  8.2 45.6  10.5 100.0  12.4
28 65.1  4.6 ** 55.6  0.6 ** 55.1  6.7 ** 100.0  1.1
29 59.7  11.6 42.9  6.7 * 43.4  0.8 * 100.0  14.7
34 64.7  11.4 44.2  5.1 ** 44.6  3.8 ** 100.0  1.7
35 59.3  14.3 52.0  6.3 ** 58.9  2.2 ** 100.0  2.9
47 56.7  12.9 44.6  1.2 ** 44.9  7.0 ** 100.0  0.8
50 48.3  7.6 * 51.2  11.2 * 41.6  3.8 * 100.0  10.2
53 64.6  12.9 45.3  2.6 ** 48.2  8.6 ** 100.0  4.4
58 58.9  2.3 ** 52.2  2.6 ** 50.7  1.3 ** 100.0  2.0
89 63.9  1.0 ** 61.6  4.2 ** 49.2  4.0 ** 100.0  1.0
ATCC 43300 63.4  5.5 ** 63.0  10.2 ** 47.5  5.4 ** 100.0  1.9
Results are expressed as the percentage of the absorbance of the positive control (presented as 100%  SD); *p < 0.05; **p < 0.01; ***p < 0.001.
lism by inhibition of NADH-cytochrome c reductase, re-
ducing the energy required for active uptake of various
metabolites and for biosynthesis of macromolecules. Since
antimicrobial activity and enzyme inhibition are not always
in correlation, Ohemeng et al. (1993) suggested that other
mechanisms can be involved.
In conclusion, results obtained in this study suggest
that tested compounds exibited strong effect on biofilm for-
mation, glycocalyx production and binding to human fibro-
nectin of MRSA strains. This effect was dose dependent
and chalcone with hydroxyl group at 2’ position of B ring
was the most effective one. Due to high antistaphylococcal
activity of evaluated chalcones and their effect on virulence
factors of MRSA strains, presented results provide useful
information for further investigations of possible applica-
tion of chalcones as promising new antimicrobial agents,
for prevention of bacterial adherence to plastic polymer
surfaces or for treatment of staphylococcal infections in
combination with conventional anti-MRSA therapy.
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